期刊文献+

归芍地黄汤加减治疗类风湿性关节炎44例临床观察

Clinical Observation on Treatment of 44 cases of Rheumatoid Arthritis With Guishao Dihuang Decoction Decoction
下载PDF
导出
摘要 目的探究对患有类风湿性关节炎患者实施加味归芍地黄汤治疗方案的临床治疗效果。方法收集我院类风湿性关节炎患者88例,给对照组44例患者实施保泰松治疗方案,治疗组患者在实施保泰松治疗同时加用加味归芍地黄汤联合治疗,治疗12周后对比两组患者治疗效果。结果治疗组治疗有效率高于对照组,差异具有统计学意义,P<0.05。结论对患有类风湿性关节炎患者实施保泰松联合加味归芍地黄汤治疗方案具有较好的临床效果。 Objective To explore the clinical effect of the treatment of patients with rheumatoid arthritis (RA) in the treatment of Jiawei Dihuang decoction. Methods 88 patients in our hospital in patients with rheumatoid arthritis, to the control group of 44 patients with phenylbutazone treatment, treatment group in the implementation ofphenylbutazone therapy combined with modified Guishao Dihuang Decoction Combined with treatment, after 12 weeks of treatment, compared two groups of patients the effect. Results The effective rate of the treatment group was higher than that of the control group, the difference was statistically significant, P〈0.05. Conclusion It's good clinical effect on patients suffering from rheumatoid arthritis patients with phenylbutazone combined with Guishao Dihuang Decoction treatment.
出处 《中国继续医学教育》 2017年第8期196-197,共2页 China Continuing Medical Education
关键词 加味归芍地黄汤 类风湿性关节炎 临床观察 jiawei dihuang decoction rheumatoid arthritis clinical observation
  • 相关文献

参考文献8

二级参考文献144

  • 1储永良,黄清春.血管内皮生长因子及其受体与类风湿关节炎的相关性[J].中华风湿病学杂志,2005,9(6):359-362. 被引量:11
  • 2潘兵.早期成人髋臼发育不良的诊断和手术治疗[J].上海医学,1995,18(1):58-62. 被引量:10
  • 3王一凡,韦登明.雷公藤内酯醇治疗类风湿关节炎分子机制的研究进展[J].中华风湿病学杂志,2005,9(10):628-630. 被引量:13
  • 4杨波,梁清华,谢薇,蔡颖,陈疆,张花先,关勇军,朱崇学.胶原诱导性关节炎大鼠滑膜病变的蛋白质组学研究[J].中华风湿病学杂志,2006,10(8):474-477. 被引量:14
  • 5Cope AP. T cells in rheumatoid arthritis. Arthritis Res Ther, 2008, 10 (Suppl 1): S1.
  • 6Zhang Z, Gorman CL, Vermi AC, et al. TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues. Blood, 2007, 109:4328-4335.
  • 7Norii M, Yamamura M, lwahashi M, Ueno A, Yamana J, Makino H. Selective recruitment of CXCR3 + and CCR5+ CCR4+ T cells into synovial tissue in patients with rheumatoid arthritis. Acta Med Okayama, 2006, 60: 149-157.
  • 8Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol, 2007, 25: 821-852.
  • 9Veldhoen M, Hocking RJ, Atkins CJ, et al. TGFbeta in the context of an inflammatory eytokine milieu supports de novo differentiation of IL-17-produeing T cells. Immunity, 2006, 24:179-189.
  • 10Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17- producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol, 2005, 6 (11): 1123 - 1132.

共引文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部